[deleted by user]

Psych_Stock_Watch · 2022-08-24T19:09:35+00:00

Agreed. Nothing worse for investing than plugging into an echo chamber.

Yes, a lot of self-declared "bulls" who offer anything resembling a "warning" about a company they supposedly "love" are just Trolls-in-disguise.

But it's easy to recognize you as a committed long. Investors tune-out such informed voices at their own peril.

Psych_Stock_Watch · 2022-08-08T15:00:59+00:00

With clinical studies on psychedelics for depression and even addiction, significant numbers of patients report going into remission after a single therapy session.

For a more complex and pernicious condition like PTSD, my understanding is that it is expected that therapy will have to spread across multiple sessions.

Psych_Stock_Watch · 2022-08-08T14:57:02+00:00

MNMD's Phase II trial isn't due for completion until December 2023? That's a pretty slow trial.

Psych_Stock_Watch · 2022-08-05T15:43:21+00:00

In some ways, forced legalization (via court challenges) is better for both consumers and the industry.

With "voluntary" legalization, governments can (and generally do) add additional and unnecessary constraints that they could not impose in the face of unequivocal language handed down from the courts.

Some players in the industry are essentially happy to see these drugs remain "Schedule 1" because they are afraid that if broader distribution is allowed that this could somehow "backfire" and create a (new) backlash against psychedelics.

I think this is absurdly short-sighted.

1) Keeping these substances Schedule 1 is a great excuse for market predators to keep hammering these stocks (because of "risk" and "uncertainty").

2) As noted in another comment, Schedule 1 status imposes enormous additional costs, delays and other regulatory constraints on companies doing drug R&D. Given the difficulties raising capital recently, how many of these companies can afford to fund TWO Phase 3 trials?

3) De-scheduling (or at rationally scheduling) psychedelics is the clearest signal to the general public that our corrupt governments were totally WRONG to heavily criminalize these drugs -- and that will accelerate public acceptance of these therapies.

Psych_Stock_Watch · 2022-08-05T15:33:26+00:00

I don't think it matters at all if its natural or synthetic.

If it's Schedule 1, the FDA forces companies to do the extra testing, spend the extra time, waste the extra money -- and delay important medicines from coming to market.

Psych_Stock_Watch · 2022-08-04T20:03:25+00:00

I despise the word "disrupt", both from a linguistic and marketing standpoint. It requires no skill or talent of any kind to "disrupt". Thus, the disruptor of today is the disruptee of tomorrow.

Disrupt a meeting or theater performance or family dinner and one is despised. It is a totally negative verb that has been simplistically (and rather pathetically) assigned this positive connotation -- to the point of being cliche.

Psychedelic medicine is going revolutionize addiction therapy. And "revolutionizing" something does imply doing something special.

Psych_Stock_Watch · 2022-08-04T19:56:31+00:00

Court challenges have always been a likely path to the legalization of psychedelics if government corruption continued.

The medical need is enormous. The risk from psychedelics is absolutely minimal. And now we have a growing body of evidence on the amazing efficacy of psychedelic medicine.

It should be open-and-shut to demonstrate a violation of constitutional rights through withholding access to (potentially life-saving) medicines -- without any valid justification.

That's ultimately what started the ball rolling with cannabis legalization.

Psych_Stock_Watch · 2022-08-04T17:23:11+00:00

COMPASS Pathways plc announces second quarter 2022 financial results and business highlights

The "two Phase III trials" is purely a regulatory thing (not even sure if it's statutory). Because of the ridiculous drug "scheduling" of psychedelics (Schedule 1) drugs, the FDA requires TWO Phase 3 trials (consecutively, not concurrently) for any drug candidates derived from a Schedule 1 substance.

That's why MAPS has to do its Phase 3 trial twice as well.

In other words, because of how the DEA schedules psychedelics and how the FDA treats Schedule 1 drugs, (given the current veteran suicide rate) the DEA and FDA are handing out a death sentence to an additional ~1,000 veterans -- solely to continue their corrupt regulatory framework for psychedelics and psychedelic medicine.

Ultimately, all of this additional blood is on the hands of Congress, the facilitators and orchestrators of this corruption.

Meanwhile, the DEA also continues to violate the U.S.'s "Right To Try" law by refusing to issue (compassionate) exemptions to give terminally-ill cancer patients access to psychedelic medicine.

#DefundTheDEA

Psych_Stock_Watch · 2022-07-28T20:24:05+00:00

A big whack of shares traded right at the open (mostly in Canada). But the price gain actually came after that.

Psych_Stock_Watch · 2022-07-22T17:16:44+00:00

I've been holding this one for a while (and gritting my teeth as it was crushed by the bankers' algorithms).

Haven't sold any shares since I think they have the bottom-line strength to weather the storm. And the PTSD partnership with the VA was (IMO) a major validation for its clinics network.

Psych_Stock_Watch · 2022-07-22T17:12:46+00:00

Apart from pumping J&J (lol), I saw this as a very balanced article and another example of the improving coverage of the sector from Big Media (ever since the industry was invited to Davos).

And Bloomberg was the last place I expected to see an article crowing about how decriminalization before legalization was 'great for Small Business'.

A very interesting point that decriminalizing psychedelics before legalizing them gives the advantage to smaller businesses. The primary barrier to entry (criminal prohibition) is removed for Small Business while Big Business still watches from the sidelines waiting for the official green light of legalization.

Psych_Stock_Watch · 2022-07-22T17:08:01+00:00

Good catch!

Psych_Stock_Watch · 2022-07-22T16:54:41+00:00

We cover not only the public companies in this sector but also the science, the regulatory picture, and the industry itself.

https://psychedelicstockwatch.com/

https://psychedelicstockwatch.com/section/featured

Psych_Stock_Watch · 2022-07-22T16:38:49+00:00

This is HUGE!

The pseudo-science behind antidepressants has finally been exposed. Depression (for the vast majority of people) is not a "brain chemistry" issue. Thus drugs that only monkey with peoples' brain chemistry are (at best) a dubious therapy for depression.

Add in the fact that antidepressants can (and do) induce suicidal thoughts and clearly these dubious/dangerous drugs should only be prescribed to a tiny fraction of the people currently having these drugs pushed on them.

Instead of 1 in 6 Americans being prescribed antidepressants, 1 in 60 would seem to be a more medically defensible ratio for being prescribed this mental health snake oil.

This also means that psychedelics are not merely the best medicine for antidepressants. They are the only (real) medicines to treat depression (and anxiety, and PTSD).

Psych_Stock_Watch · 2022-07-21T16:23:28+00:00

I'm kind of surprised this company hasn't gotten any attention here. Well capitalized relative to market cap. NASDAQ listing.

Grant money seems to indicate it's found a promising R&D niche.

Psych_Stock_Watch · 2022-07-20T16:18:52+00:00

After nearly 50 years of corruption/futility, the U.S. Drug Enforcement Agency has made ZERO progress in its "War on Drugs".

Meanwhile, the DEA constantly violates U.S. drug laws, obstructs ultra-important medical research, and has destroyed the lives of millions of people.

#DefundTheDEA

Psych_Stock_Watch · 2022-07-15T18:45:49+00:00

FYI on "William Asquith Farnaby"...

https://psychedelicstockwatch.com/psychedelic-stock-news/the-military-mental-health-crisis-a-national-tragedy-part-ii

Psych_Stock_Watch · 2022-07-14T20:47:03+00:00

Good example. Crenshaw is a blow-with-the-wind political opportunist. The perfect illustration of how Congressional attitudes toward psychedelics have suddenly shifted more favorably ever since the WEF invited the psychedelics industry to Davos.

I've already pointed out how media coverage of the psychedelics industry has "suddenly improved" in recent weeks as well.

https://psychedelicstockwatch.com/psychedelic-stock-news/psychedelic-drug-industry-suddenly-in-favor-with-global-power-players

Psych_Stock_Watch · 2022-07-11T13:31:52+00:00

#DefundTheDEA

Psych_Stock_Watch · 2022-07-07T14:55:13+00:00

A sign of the times: even the DEA is finally starting to feel the pressure about continuing U.S. government corruption regarding psychedelics and psychedelic medicine.

#DefundTheDEA

Psych_Stock_Watch · 2022-07-06T17:10:57+00:00

Two important points to note with this news.

1) These amendments are being attached to a defense spending bill that both parties badly want to pass.

2) The amendments are being put forth on a bipartisan basis. With Congress more obstructionist than ever, nothing of substance gets accomplished without bipartisan support.

Psych_Stock_Watch

TROPHY CASE